SCHEMBL977093

SCHEMBL977093

O=C(NCc1ccccc1)c1ccc(C2(c3ccc(OCc4ccccn4)cc3)CCC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.54
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
HPGD P15428 2/20 0.51
HSD17B10 Q99714 1/20 0.51
PARP10 Q53GL7 1/20 0.49
SMN1; SMN2 Q16637 6/20 0.48
POLB P06746 3/20 0.48
MDM2 Q00987 1/20 0.48
LMNA P02545 3/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
HDAC1 Q13547 2/20 0.47
HTT P42858 3/20 0.47
CYP3A4 P08684 1/20 0.47
MMP13 P45452 1/20 0.47
KDM4E B2RXH2 1/20 0.46
HPGDS O60760 1/20 0.46
CYSLTR1 Q9Y271 1/20 0.46
ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL975592 0.98 MAPK14 (0.54) MAPK14MEN1KMT2AHPGDHSD17B10
SCHEMBL977198 0.96 MAPK14 (0.56) MAPK14MEN1KMT2AHPGDHSD17B10
SCHEMBL977750 0.91 MEN1 (0.51) MAPK14MEN1KMT2AHPGDHSD17B10
SCHEMBL976571 0.91 MAPK14 (0.51) MAPK14MEN1KMT2AHPGDHSD17B10
SCHEMBL975447 0.85 PARP10 (0.53) MAPK14MEN1KMT2AHPGDHSD17B10
SCHEMBL975580 0.85 PARP10 (0.57) MAPK14HPGDPARP10SMN1; SMN2KDM4E
SCHEMBL977936 0.84 SMN1; SMN2 (0.49) MAPK14MEN1KMT2AHPGDHSD17B10
SCHEMBL976548 0.84 PARP10 (0.51) MAPK14MEN1KMT2AHPGDHSD17B10
SCHEMBL975604 0.83 PARP10 (0.53) MAPK14MEN1KMT2AHPGDHSD17B10
SCHEMBL975183 0.83 PARP10 (0.56) MAPK14MEN1KMT2AHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110003815-A1 DIPHENYL SUBSTITUTED CYCLOALKANES MERCK & CO., INC. 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003815-A1 DIPHENYL SUBSTITUTED CYCLOALKANES PTGIS, PTGS1, LTC4S MAPK14 2934/4885MEN1 4828/4885KMT2A 4659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.